Patent directory · USPTO A61K / A61P
Patents matching “Sangamo Therapeutics, Inc.”
106 pharma patents match "Sangamo Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 106 pharmaceutical patents matching "Sangamo Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12318427
Methods and compositions for modulation of tau proteins
granted -
US 12139517
Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof
granted -
US 12043650
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted -
US 11981967
Engineering AAV
granted -
US 11920169
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11898158
Methods and compositions for the treatment of lysosomal storage diseases
granted -
US 11857641
Method for the treatment of mucopolysaccharidosis type I
granted -
US 11859190
Methods and compositions for regulation of transgene expression
granted -
US 11845965
Regulation of gene expression using engineered nucleases
granted -
US 11827900
Engineered target specific nucleases
granted -
US 11793888
Methods and compositions for engineering immunity
granted -
US 11723952
Methods and compositions for treating Huntington's Disease
granted -
US 11718834
Compositions and methods for producing recombinant AAV
granted -
US 11690921
Delivery of target specific nucleases
granted -
US 11661612
DNA-binding proteins and uses thereof
granted -
US 11661611
Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
granted -
US 11655275
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted -
US 11649468
Targeted integration into the PPP1R12C locus
granted -
US 11648267
Methods and compositions for gene inactivation
granted -
US 11639504
Methods and compositions for regulation of transgene expression
granted -
US 11634463
Methods and compositions for treating hemophilia
granted -
US 11608492
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 11591622
Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder
granted -
US 11512287
Targeted disruption of T cell and/or HLA receptors
granted